299
Views
18
CrossRef citations to date
0
Altmetric
Research Article

CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis

, , , , , , & show all
Pages 180-188 | Received 30 Aug 2013, Accepted 15 Dec 2013, Published online: 03 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Boyang Zhou, Mojun Chen, Shuai Shang & Jian Zhao. (2022) Association of CTLA-4 gene polymorphisms and alopecia areata: a systematic review and meta-analysis. Biomarkers 27:4, pages 338-348.
Read now

Articles from other publishers (17)

Alin-Dan Chiorean, Mihaela Laura Vica, Ștefana Bâlici, Gheorghe Zsolt Nicula, Nicoleta Răcătăianu, Mădălina Adriana Bordea, Laura-Mihaela Simon & Horea Vladi Matei. (2023) The C55A Single Nucleotide Polymorphism in CTLA-4 Gene, a New Possible Biomarker in Thyroid Autoimmune Pathology Such as Hashimoto’s Thyroiditis. Diagnostics 13:15, pages 2517.
Crossref
Hernando Vargas-Uricoechea. (2023) Molecular Mechanisms in Autoimmune Thyroid Disease. Cells 12:6, pages 918.
Crossref
Aditi Saha, Isabella Dreyfuss, Humaira Sarfraz, Mark Friedman & Joseph Markowitz. (2022) Dietary Considerations for Inflammatory Bowel Disease Are Useful for Treatment of Checkpoint Inhibitor-Induced Colitis. Cancers 15:1, pages 84.
Crossref
Mauricio Andrés Salinas-Santander, Víctor de Jesús Suárez-Valencia, Mayela del Ángel-Martínez, David Emmanuel Kubelis-Lopez, Natalia Aranza Zapata-Salazar, Jorge Alejandro Ocampo-Garza & Jorge Ocampo-Candiani. (2022) Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population. Anais Brasileiros de Dermatologia 97:6, pages 710-715.
Crossref
Elias de França, Ronaldo V. T. dos Santos, Liliana C. Baptista, Marco A. R. Da Silva, André R. Fukushima, Vinícius B. Hirota, Raul A. Martins & Erico C. Caperuto. (2022) Potential Role of Chronic Physical Exercise as a Treatment in the Development of Vitiligo. Frontiers in Physiology 13.
Crossref
Ghazwan A. Hasan & Ibrahim A. Altamemi. (2022) CTLA-4 POLYMORPHISM ALONG WITH PROINFLAMMATORY CYTOKINES IN AUTOIMMUNE THYROIDITIS DISEASE. Wiadomości Lekarskie 75:3, pages 577-583.
Crossref
Mathilde Peiffert, Christine Cugnet-Anceau, Stephane Dalle, Karim Chikh, Souad Assaad, Emmanuel Disse, Gérald Raverot, Françoise Borson-Chazot & Juliette Abeillon-du Payrat. (2021) Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review). Cancers 13:8, pages 1944.
Crossref
Natalia Zeber-Lubecka & Ewa E. Hennig. (2021) Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis: How Far Is Our Understanding?. Frontiers in Immunology 12.
Crossref
Kamil Dyrka, Daria Witasik, Agata Czarnywojtek & Katarzyna Łącka. (2021) The influence of monoclonal antibodies for cancer treatment on the endocrine system. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 317-327.
Crossref
Natássia Elena Bufalo, Roberto Bernardo dos Santos, Angélica Gomes Rocha, Larissa Teodoro, João Hamilton Romaldini & Laura Sterian Ward. (2020) Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves’ disease: susceptibility and clinical features. Endocrine 71:1, pages 104-112.
Crossref
Xin‐Rui Han, Xin Wen, Shan Wang, Shao‐Hua Fan, Juan Zhuang, Yong‐Jian Wang, Zi‐Feng Zhang, Meng‐Qiu Li, Bin Hu, Qun Shan, Chun‐Hui Sun, Ya‐Xing Bao, Dong‐Mei Wu, Jun Lu & Yuan‐Lin Zheng. (2018) Correlations of CTLA‐4 exon‐1 49 A/G and promoter region 318C/T polymorphisms with the therapeutic efficacy of 131 I radionuclide in graves’ disease in Chinese Han population . Journal of Cellular Biochemistry 119:8, pages 6383-6390.
Crossref
Monica Girotra, Aaron Hansen, Azeez Farooki, David J Byun, Le Min, Ben C Creelan, Margaret K Callahan, Michael B Atkins, Elad Sharon, Scott J Antonia, Pamela West & Amy E Gravell. (2018) The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management. JNCI Cancer Spectrum 2:3.
Crossref
Yifang HuKuanfeng XuLin JiangLijuan ZhangHe ShiDai Cui. (2018) Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis . Genetic Testing and Molecular Biomarkers.
Crossref
Oksana D. Rymar, Anna K. Mikitinskaya, Vladimir N. Maksivov, Sergei G. Shahmatov, Yuliya V. Schepina, Andrew N. Ryabikov & Svetlana V. Mustafina. (2016) Association of candidate gene polymorphisms for autoimmune thyroid diseases in patients with familial diffuse toxic goiter and autoimmune thyroiditis. Clinical and experimental thyroidology 12:2, pages 46.
Crossref
Hinal Patel, Mohmmad Shoab Mansuri, Mala Singh, Rasheedunnisa Begum, Minal Shastri & Ambikanandan Misra. (2016) Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism. PLOS ONE 11:3, pages e0149441.
Crossref
A. M. Dickinson & J. Norden. (2015) Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?. International Journal of Immunogenetics 42:4, pages 229-238.
Crossref
Hai-Feng Hou, Xu Jin, Tao Sun, Cheng Li, Bao-Fa Jiang & Qun-Wei Li. (2015) Cytotoxic T Lymphocyte-Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Diseases: An Updated Systematic Review and Cumulative Meta-Analysis. International Journal of Endocrinology 2015, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.